Biotechnology

Imperial’s interdisciplinary expertise in biotechnology leads the UK field and spans many disciplines. Many of our experts work together as part of the Industrial Biotechnology Hub and Agri-Net which are dedicated to developing innovative solutions for industry and government agencies.

Areas of expertise include…

 

Biotechnology

Synthetic biology, biocatalysis and metabolic engineering, bioinformatics, metabolomics, proteomics, glycomics, nanotechnology, imaging, image analysis and information systems, artificial bioactive material and implants plus neurotechnology.

 

Applied Biosciences

Bioenergy/biorenewables, bioremediation and waste treatment, bioprocessing and bioseparations, biologics, implants, regenerative medicine and tissue engineering, agri-food, brain-related illnesses and blast injury.

 

Microbial Strain Engineering, Design and Improvement.

With increased environmental and economic constraints on industries, the bioproduction of molecules is becoming a sustainable alternative to traditional methods. To scale it up to industrial production, we still need significant improvements in the methods, using genetic engineering and metabolic engineering.

Engineered micro-organisms have a wide range of applications in

  • Oil and Gas – e.g. production of biodiesel, biokerosene, hydrogen, and electricity from renewable sources
  • Pharmaceuticals – e.g. production of active compounds, biosensors, microbiome engineering
  • Chemicals – e.g. production of bulk chemicals or high value compounds
  • Engineering – e.g. production of novel materials and biological circuits
  • Defence

Dr Rodrigo Ledesma-Amaro’s group at Imperial have a vast knowledge of microbial metabolism, and its regulation, in organisms ranging from yeast and fungi to bacteria. Through engineering-based improvements – such as increasing resistance to inhibitors, enabling the use of low-cost substrates and maximising the production of a desired compound – they can ‘tailor’ micro-organisms to perform desired tasks in a cost-efficient manner – and guide you on the downstream process.

The group’s expertise includes:

  • Development of synthetic biology, metabolic engineering and molecular biology tools.
  • Rational metabolic engineering for bioproduction.
  • Metabolic modelling as a tool to identify engineering targets.
  • Decreasing bioproduction cost by strain improvement at different levels.
  • Reliable chassis strains generation.
  • Selecting the best host for each product and process.
  • High-throughput strain improvement techniques.

 

Experts include:

Dr Rodrigo Ledesma-Amaro – leads a research group at the interface of synthetic biology and metabolic engineering. His expertise includes microbial biotechnology and communities, applications in industrial biotechnology and biomedicine.

Advisory services

Product design, research methods, data analysis, technology evaluation for investment, technological innovation, patent evaluation, prototype and protocol development, policy, cyber security and more. Assisting museums, writers, film makers and artists to ensure creations scientifically sound.

Expert insight

Membership of Scientific Advisory Boards and Technical Panels, advice and guidance on drug development programmes, thought leadership, conference speakers, literature reviews and provision of foresight.

Analysis and testing

Use of the world-class specialist facilities and technicians at Imperial for projects ranging from aerodynamic measurements and medical imaging to structural testing and analysis.

Our consultants are world-leading experts in their field, committed to on-going research.

Related Insights

Decision-making under uncertainty

Decision-making under uncertainty

Decision-making under uncertainty - Read how Imperial academics are helping companies maximise performance even in highly uncertain times. read more

Life after lockdown: Research and development

Life after lockdown: Research and development

With lockdown and limited access to labs in-house R&D is proving difficult and costly right now. Imperial's experts can undertake testing, review tech or offer their tech under licence. read more

Related case studies

Hepatitis C genotype and drug resistance testing

Hepatitis C genotype and drug resistance testing

Genotype and resistance testing for new direct-acting antiviral (DAA) drugs designed to treat Hepatitis C virus (HCV). read more

Scottish health service delivery and performance

Scottish health service delivery and performance

Our consultants shared their expertise in acute medicine and experience of working for governmental organisations and the NHS to help NHS Scotland and the Scottish Government to improve efficiency and quality in the Scottish health service. read more

Global adoption and regulation of electronic medical records

Global adoption and regulation of electronic medical records

Our consultants shared their expertise in clinical medicine to help IMS Health to assess the adoption, governance and regulatory landscape of electronic medical records (EMR) at different levels of healthcare systems around the world. read more

Latest news

Professor Simon Taylor-Robinson appears in primetime BBC One health programme

Professor Simon Taylor-Robinson appears in primetime BBC One health programme

“Long Live Britain”, which was broadcast on Monday 5th August 2013 at 9pm on BBC One, documented a record-breaking health screening aimed at challenging the way that we tackle three of Britain’s most dominant preventable diseases. read more

Energy tech helping UK meet net zero emissions

Energy tech helping UK meet net zero emissions

Studies by Imperial's academics for energy companies Drax and SSE Renewables offer expert insight into the energy technologies that could help the UK meet its target of net zero carbon dioxide emissions by 2050. read more

Imperial part of London Alliance offering 20,500 more COVID tests a day by March

Imperial part of London Alliance offering 20,500 more COVID tests a day by March

Imperial joins Department of Health and Social Care's partnership with the London Testing Alliance, brought together by life science cluster MedCity to ramp up testing. read more